<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This retrospective study examined the effectiveness of cilostazol in preventing <z:hpo ids='HP_0011951'>aspiration pneumonia</z:hpo> in patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The 189 subjects ranged in age from 31 to 95 years and included 57 with small-<z:mp ids='MP_0006134'>artery occlusion</z:mp>, 107 with large-artery atherothrombosis, and 25 with other disorders </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with cardiogenic <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> or preexisting <z:hpo ids='HP_0002090'>pneumonia</z:hpo> at the time of hospital admission were excluded from the analysis </plain></SENT>
<SENT sid="3" pm="."><plain>Neurologic symptoms, cognitive function, and swallowing function were assessed at the first clinical examination, and the ability to perform activities of daily living was assessed at both hospital admission and discharge </plain></SENT>
<SENT sid="4" pm="."><plain>Outcome and food intake status were also assessed at hospital discharge </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002090'>Pneumonia</z:hpo> was detected in 27 of 189 subjects (14.3%), in 20 subjects during nasogastric tube feeding implemented because of oral intake difficulties (fasting group) and in 7 subjects after initiation of oral feeding (oral intake group) </plain></SENT>
<SENT sid="6" pm="."><plain>Cilostazol was administered to 48 of the 189 subjects (25.4%) </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of <z:hpo ids='HP_0002090'>pneumonia</z:hpo> was 6.3% (3 of 48) in patients who received cilostazol, compared with 17% (24 of 141) in those who did not receive cilostazol </plain></SENT>
<SENT sid="8" pm="."><plain>Our data suggest that cilostazol appears to prevent the occurrence of <z:hpo ids='HP_0002090'>pneumonia</z:hpo> in both the <z:hpo ids='HP_0011010'>chronic</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> stages of <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>